Myasthenia gravis steroid therapy

Caution should be used when high-dose prednisone is given to patients as up to 50% of patients may develop a transient deterioration with possible precipitation of MG crisis. The transient worsening usually occurs 5 to 10 days after dose initiation and lasts for about a week. For this reason, high-dose prednisone should be started in hospitalized patients receiving concurrent rapid induction immunotherapy. Alternatively, a slow dose escalation regimen should be used to reach a target dose of 1mg/kg (usually 50-80 mg/day) over 3 to 4 weeks. In patients with mild to moderate MG symptoms, a lower dose of 20 to 40 mg per day is sufficient.

Myasthenia gravis steroid therapy

myasthenia gravis steroid therapy

Media:

myasthenia gravis steroid therapymyasthenia gravis steroid therapymyasthenia gravis steroid therapymyasthenia gravis steroid therapymyasthenia gravis steroid therapy